cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Eiger Biopharmaceuticals Inc
9 own
14 watching
Current Price
$0.32
$0
(-0.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
14.36M
52-Week High
52-Week High
3.96000
52-Week Low
52-Week Low
0.21000
Average Volume
Average Volume
0.21M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization14.36M
icon52-Week High3.96000
icon52-Week Low0.21000
iconAverage Volume0.21M
iconDividend Yield--
iconP/E Ratio--
What does the Eiger Biopharmaceuticals Inc do?
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company s product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.
Read More
How much money does Eiger Biopharmaceuticals Inc make?
News & Events about Eiger Biopharmaceuticals Inc.
Ticker Report
7 months ago
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR Get Rating) was the recipient of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,710,000 shares, an increase of 9.3% from the March 31st total of 2,480,000 shares. Based on an average daily ...
Zolmax
7 months ago
Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR Get Rating) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 2,710,000 shares, an increase of 9.3% from the March 31st total of 2,480,000 shares. Based on an average daily volume of ...
PR Newswire
7 months ago
Thinking about buying stock in Bit Digital, Cipher Mining, Eiger Biopharmaceuticals, Eos Energy, or Bitfarms? Thinking about buying stock in Bit Digital, Cipher Mining, Eiger Biopharmaceuticals, Eos Energy, or Bitfarms? PR Newswire NEW YORK, April 13, 2023 NEW YORK, April 13, 2023 /PRNewswire...
Globe Newswire
9 months ago
PHILADELPHIA, March 06, 2023 (GLOBE NEWSWIRE) -- Investor protection law firm Kaskela Law LLC announces that it is investigating Eiger BioPharmaceuticals, Inc. (Eiger or the Company) (NASDAQ: EIGR) on behalf of the Companys long-term stockholders. Recently a shareholder class action complaint was ...
PR Newswire
11 months ago
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm PR Newswire LOS...
Frequently Asked Questions
Frequently Asked Questions
What is Eiger Biopharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Eiger Biopharmaceuticals Inc shares?
plus_minus_icon
How can I buy Eiger Biopharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Eiger Biopharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Eiger Biopharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Eiger Biopharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Eiger Biopharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Eiger Biopharmaceuticals Inc?
plus_minus_icon
What percentage is Eiger Biopharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Eiger Biopharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.32
$0
(-0.03%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00